XML 34 R24.htm IDEA: XBRL DOCUMENT v3.23.3
Stock Based Compensation (Tables)
9 Months Ended
Sep. 30, 2023
Share-Based Payment Arrangement [Abstract]  
Summary of Option Activity Under Company's Equity Incentive Plans

The following table summarizes stock option activity under the Company’s 2018 Plan and related information:

 

 

Number of Shares
Underlying
Outstanding
Options

 

 

Weighted-
Average Exercise
Price

 

 

Weighted-
Average
Remaining
Contractual Term
(Years)

 

Outstanding — December 31, 2022

 

 

8,678,767

 

 

$

1.42

 

 

 

7.47

 

Options granted (1)

 

 

14,008,093

 

 

$

0.86

 

 

 

 

Options exercised

 

 

(215,067

)

 

$

0.10

 

 

 

 

Options forfeited and cancelled (1)

 

 

(14,210,119

)

 

$

0.91

 

 

 

 

Options expired

 

 

(14,729

)

 

$

34.33

 

 

 

 

Outstanding — September 30, 2023

 

 

8,246,945

 

 

$

1.32

 

 

 

5.43

 

Exercisable — September 30, 2023

 

 

7,609,393

 

 

$

1.37

 

 

 

 

 

(1)
Includes options that were cancelled and re-granted as part of the option modification from the special cash dividend, as further discussed above.
Summary of Weighted Average Valuation Assumptions Used to Estimate Fair Value of Employee Stock Options

The fair value of employee stock options was estimated using the following weighted-average assumptions:

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

 

2023

 

2022

 

 

2023

 

2022

 

Employee Stock Options:

 

 

 

 

 

 

 

 

 

 

Risk-free interest rate

 

n/a

 

 

3.02

%

 

n/a

 

 

2.25

%

Expected term (in years)

 

n/a

 

 

6.1

 

 

n/a

 

 

6.0

 

Dividend yield

 

n/a

 

 

 

 

n/a

 

 

 

Volatility

 

n/a

 

 

91.61

%

 

n/a

 

 

91.63

%

Weighted-average fair value of stock options granted

 

n/a

 

$

1.34

 

 

n/a

 

$

0.58

 

Summary of Stock-Based Compensation Expense Recognized

Total stock-based compensation expense recognized was as follows (in thousands):

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

 

2023

 

 

2022

 

 

2023

 

 

2022

 

Research and development

 

$

 

 

$

78

 

 

$

67

 

 

$

289

 

General and administrative(1)

 

 

98

 

 

 

146

 

 

 

330

 

 

 

796

 

Total stock-based compensation expense

 

$

98

 

 

$

224

 

 

$

397

 

 

$

1,085

 

 

 

(1)
No shares of common stock were issued to Board members for the three and nine months ended September 30, 2023.